Table 1 Clinical features, risk factors, and laboratory data of the cohort
From: Expression of circulating miR-486 and miR-150 in patients with acute myocardial infarction
Characteristics | All cohort (n = 220) | AMI cases (n = 110) | Control cases (n = 110) | P | |
|---|---|---|---|---|---|
STEMI (n = 65) | NSTEMI (n = 45) | ||||
Age (years) | 57.99 ± 11.63 | 57.54 ± 12.07 | 57.93 ± 11.98 | 58.28 ± 11.32 | 0.712 |
Men/women (n/n) | 170/50 | 51/14 | 36/9 | 83/27 | 0.520 |
Risk factors | |||||
Hypertension (Y/N) | 103/117 | 34/31 | 17/28 | 52/58 | 0.893 |
Hyperlipidemia (Y/N) | 26/119 | 9/56 | 3/42 | 14/96 | 0.676 |
Diabetes mellitus (Y/N) | 50/170 | 13/52 | 10/35 | 27/83 | 0.520 |
Smoking (Y/N) | 47/173 | 15/50 | 8/37 | 24/86 | 0.869 |
Physical examination | |||||
SBP (mmHg) | 124.64 ± 18.89 | 125.88 ± 21.51 | 121.76 ± 16.35 | 124.23 ± 20.26 | 0.754 |
DBP (mmHg) | 75.95 ± 11.58 | 76.68 ± 13.70 | 73.31 ± 9.60 | 77.30 ± 10.68 | 0.132 |
Heart rate (beats/ min) | 74.10 ± 12.98 | 74.20 ± 13.03 | 75.38 ± 11.54 | 73.53 ± 13.57 | 0.511 |
Lab examination | |||||
TC (mmol/L) | 3.9232 ± 0.99 | 3.91 ± 1.07 | 3.92 ± 1.09 | 3.90 ± 0.91 | 0.998 |
TG (mmol/L) | 1.3727 ± 0.80 | 1.48 ± 1.17 | 1.39 ± 0.88 | 1.30 ± 0.42 | 0.197 |
HDL (mmol/L) | 1.0470 ± 0.22 | 0.98 ± 0.23 | 1.05 ± 0.27 | 1.09 ± 0.18 | 0.080 |
LDL (mmol/L) | 2.5300 ± 1.00 | 2.52 ± 0.97 | 2.43 ± 0.87 | 2.58 ± 1.08 | 0.504 |
WBC (×109/L) | 8.589 ± 3.62 | 9.51 ± 4.13 | 10.02 ± 4.01 | 7.46 ± 2.68 | <0.001 |
BUN (mmol/L) | 5.9365 ± 2.73 | 6.25 ± 3.05 | 6.16 ± 2.64 | 5.66 ± 2.55 | 0.135 |
CK-MB (U/L) | 35.68 ± 59.13 | 58.80 ± 90.75 | 48.46 ± 58.17 | 16.79 ± 8.63 | <0.001 |
Cardiac troponin T (ng/mL) | 0.68 ± 1.40 | 1.44 ± 1.89 | 1.16 ± 1.57 | 0.05 ± 0.12 | <0.001 |
EF% | 58.14 ± 7.83 | 56.35 ± 7.89 | 55.80 ± 8.28 | 60.15 ± 7.13 | <0.001 |